Utah Medical Products (UTMD) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $2.6 million.
- Utah Medical Products' Profit After Tax fell 2615.77% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 2383.51%. This contributed to the annual value of $13.9 million for FY2024, which is 1659.75% down from last year.
- According to the latest figures from Q3 2025, Utah Medical Products' Profit After Tax is $2.6 million, which was down 2615.77% from $3.0 million recorded in Q2 2025.
- Utah Medical Products' Profit After Tax's 5-year high stood at $4.6 million during Q4 2022, with a 5-year trough of $2.6 million in Q3 2025.
- Over the past 5 years, Utah Medical Products' median Profit After Tax value was $3.9 million (recorded in 2023), while the average stood at $3.7 million.
- As far as peak fluctuations go, Utah Medical Products' Profit After Tax surged by 16092.92% in 2021, and later tumbled by 3230.7% in 2024.
- Utah Medical Products' Profit After Tax (Quarter) stood at $4.1 million in 2021, then rose by 10.26% to $4.6 million in 2022, then dropped by 5.88% to $4.3 million in 2023, then crashed by 32.31% to $2.9 million in 2024, then dropped by 9.34% to $2.6 million in 2025.
- Its Profit After Tax stands at $2.6 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.0 million for Q1 2025.